Who are ethinyl estradiol + levonorgestrel + folic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Drospirenone Ethinyl estradiol Myo-inositol, Kariva®, Ortho Tri-Cyclen LO, All participants (Aviane), YAZ®, norelgestromin + ethinyl estradiol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ethinyl-estradiol-levonorgestrel-folic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

ethinyl estradiol + levonorgestrel + folic acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ethinyl estradiol + levonorgestrel + folic acid (ethinyl estradiol + levonorgestrel + folic acid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oral contraceptive with folic acid supplementation. Area: Contraception / Women's Health.

phase 3 Oral contraceptive with folic acid supplementation Progesterone receptor, estrogen receptor Contraception / Women's Health Small molecule Live · refreshed every 30 min

Target snapshot

ethinyl estradiol + levonorgestrel + folic acid (ethinyl estradiol + levonorgestrel + folic acid) — Galeno Desenvolvimento de Pesquisas Clínicas. This combination oral contraceptive suppresses ovulation through progestin and estrogen activity while folic acid supplementation reduces neural tube defect risk in pregnancy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
ethinyl estradiol + levonorgestrel + folic acid TARGET	ethinyl estradiol + levonorgestrel + folic acid	Galeno Desenvolvimento de Pesquisas Clínicas	phase 3	Oral contraceptive with folic acid supplementation	Progesterone receptor, estrogen receptor
Drospirenone Ethinyl estradiol Myo-inositol	Drospirenone Ethinyl estradiol Myo-inositol	AGUNCO Obstetrics and Gynecology Centre	marketed	Oral contraceptive with insulin sensitizer	Progesterone receptor, estrogen receptor, inositol signaling pathway
Kariva®	Kariva®	Teva Branded Pharmaceutical Products R&D, Inc.	marketed	Oral contraceptive (combined hormonal contraceptive)	Progesterone receptor, estrogen receptor
Ortho Tri-Cyclen LO	Ortho Tri-Cyclen LO	Bristol-Myers Squibb	marketed	Oral contraceptive (combined hormonal contraceptive)	Progesterone receptor, estrogen receptor
All participants (Aviane)	All participants (Aviane)	Oregon Health and Science University	marketed	Oral contraceptive (combined estrogen-progestin)	Progesterone receptor, estrogen receptor
YAZ®	YAZ®	Teva Pharmaceuticals USA	marketed	Oral contraceptive (combined estrogen-progestin)	Progesterone receptor, estrogen receptor, mineralocorticoid receptor
norelgestromin + ethinyl estradiol	norelgestromin + ethinyl estradiol	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	marketed	Combined oral contraceptive (progestin + estrogen)	Progesterone receptor, estrogen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oral contraceptive with folic acid supplementation class)

Galeno Desenvolvimento de Pesquisas Clínicas · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ethinyl estradiol + levonorgestrel + folic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-levonorgestrel-folic-acid. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab